RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2009;20:384-386
doi:10.1258/ijsa.2008.008309
© 2009 Royal Society of Medicine Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Schwartz, J L
Right arrow Articles by Callahan, M M
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original research articles

Safety evaluation of 1% tenofovir gel in healthy men

J L Schwartz MD * , A Poindexter MD {dagger}, A Wheeless BSPH {ddagger}, C K Mauck MD * and M M Callahan M.Ed *

* Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209; {dagger} Advances in Health, Inc., Houston, TX 77030; {ddagger} Family Health International, Research Triangle Park, NC 27713, USA

Correspondence to: Dr J L Schwartz, CONRAD, 1911 Fort Meyer Drive, Suite 900, Arlington, VA 22209, USA Email: jschwartz{at}conrad.org

This study was conducted to determine the safety of tenofovir (TFV) gel, a potential microbicide, following seven consecutive daily penile applications. Eighteen circumcised and 18 uncircumcised healthy men were randomly assigned to TFV gel versus K-Y® Jelly in a 2:1 ratio within circumcision group. TFV gel or K-Y Jelly was applied onto the penis at bedtime and washed off 6–10 hours later. Safety was assessed by reported symptoms, findings and laboratory tests. Three of 24 (13%) men in the TFV group reported mild genital symptoms compared with two of 11 (18%) men in the K-Y group. Few mild genital findings were observed and no significant systemic toxicities were reported or observed. TFV gel applied to the penis for seven days was well tolerated locally and systemically and it is unlikely that male partners exposed to small amounts of TFV gel will experience significant genital or systemic toxicity.

Key Words: microbicides • HIV prevention • tenofovir gel • antiretroviral


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Units Symbols and Abbreviations Sixth edition